Hemoglobin level variability: associations with mortality
David T Gilbertson, James P Ebben, Robert N Foley, Eric D Weinhandl, Brian D Bradbury, Allan J Collins, David T Gilbertson, James P Ebben, Robert N Foley, Eric D Weinhandl, Brian D Bradbury, Allan J Collins
Abstract
Background/objectives: Awareness of hemoglobin level variability in dialysis patients is increasing, as is interest in its potential implications. In this retrospective, national study of associations between the degree of hemoglobin level variability in the first 6 mo of 2004 and subsequent mortality rates in the following 6 mo, 159,720 hemodialysis patients receiving epoetin therapy were studied.
Design, setting, participants, measurements: Monthly hemoglobin values were categorized as low (L; < 11 g/dl), intermediate (I; 11 to 12.5 g/dl), and high (H; >12.5 g/dl). Variability groups were classified on the basis of the lowest and highest hemoglobin categories seen during the 6-mo observation period: low-low (L-L), 1.4%; intermediate-intermediate (I-I), 6.0%; high-high (H-H), 2.3%; low-intermediate (L-I), 18.3%; intermediate-high (I-H), 31.7%, and low-high (L-H), 40.2%.
Results: On multivariate analysis, adjusted hazards ratios for subsequent mortality events were as follows: I-I, 1.0 (reference category); I-H, 1.02 (95% confidence interval [CI] 0.95 to 1.11); H-H, 1.06 (95% CI 0.93 to 1.21); L-H, 1.19 (95% CI 1.10 to 1.28); L-I, 1.44 (95% CI 1.33 to 1.56), and L-L, 2.18 (95% CI 1.93 to 2.45). Persistently and transiently low hemoglobin levels and highly variable hemoglobin levels were associated with increased risk of death; transiently and persistently high hemoglobin levels were not associated with increased risk of death. Bayesian modeling indicated that > or =3 mo with hemoglobin levels <11 g/dl may be associated with of increased risk of death.
Conclusions: Number of months with hemoglobin values below the target range, rather than hemoglobin variability itself, may be the primary driver of increased risk of death. Further research is needed to distinguish cause from effect and to understand the underlying mechanisms.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2390986/bin/cjn0010824560001.jpg)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2390986/bin/cjn0010824560002.jpg)
Figure 3.
Interval Poisson model examining the…
Figure 3.
Interval Poisson model examining the change in hazard ratios over follow-up time. Number…
- Anemia of chronic kidney disease.Singh AK. Singh AK. Clin J Am Soc Nephrol. 2008 Jan;3(1):3-6. doi: 10.2215/CJN.05131107. Epub 2007 Dec 12. Clin J Am Soc Nephrol. 2008. PMID: 18077779 No abstract available.
- Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL.Bradbury BD, Danese MD, Gleeson M, Critchlow CW. Bradbury BD, et al. Clin J Am Soc Nephrol. 2009 Mar;4(3):630-7. doi: 10.2215/CJN.03580708. Epub 2009 Mar 4. Clin J Am Soc Nephrol. 2009. PMID: 19261826 Free PMC article.
- Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.Servilla KS, Singh AK, Hunt WC, Harford AM, Miskulin D, Meyer KB, Bedrick EJ, Rohrscheib MR, Tzamaloukas AH, Johnson HK, Zager PG. Servilla KS, et al. Am J Kidney Dis. 2009 Sep;54(3):498-510. doi: 10.1053/j.ajkd.2009.05.007. Epub 2009 Jul 23. Am J Kidney Dis. 2009. PMID: 19628315
- Hemoglobin level variability: anemia management among variability groups.Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ. Gilbertson DT, et al. Am J Nephrol. 2009;30(6):491-8. doi: 10.1159/000243565. Epub 2009 Sep 29. Am J Nephrol. 2009. PMID: 19786739 Review.
- Effect of anemia and hyperhomocysteinemia on mortality of patients on hemodialysis.Anees M, Mumtaz A, Ibrahim M, Shaheen SM, Asghar A. Anees M, et al. Iran J Kidney Dis. 2010 Jan;4(1):60-5. Iran J Kidney Dis. 2010. PMID: 20081306
- Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.Brattich M. Brattich M. Nephrol Nurs J. 2006 Jan-Feb;33(1):64-7, 90; quiz 68-9. Nephrol Nurs J. 2006. PMID: 16538929 Review.
- Neuromuscular and Muscle Tissue Hemodynamic Responses When Exposed to Normobaric Hypoxia during Lower-Body Fatiguing Muscle Actions.Smith CM, Salmon OF, Jenkins JR. Smith CM, et al. J Musculoskelet Neuronal Interact. 2023 Mar 1;23(1):26-35. J Musculoskelet Neuronal Interact. 2023. PMID: 36856097 Free PMC article.
- Recent Advances in Biosensor Technologies for Point-of-Care Urinalysis.Hwang C, Lee WJ, Kim SD, Park S, Kim JH. Hwang C, et al. Biosensors (Basel). 2022 Nov 15;12(11):1020. doi: 10.3390/bios12111020. Biosensors (Basel). 2022. PMID: 36421138 Free PMC article. Review.
- Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.Magrowski Ł, Masri O, Ciepał J, Depowska G, Nowicka Z, Stando R, Chimiak K, Bylica G, Czapla B, Masri M, Cichur F, Jabłońska I, Gmerek M, Wojcieszek P, Krzysztofiak T, Sadowski J, Suwiński R, Rajwa P, Moll M, Goldner G, Majewski W, Miszczyk M. Magrowski Ł, et al. Biomedicines. 2022 Oct 8;10(10):2514. doi: 10.3390/biomedicines10102514. Biomedicines. 2022. PMID: 36289778 Free PMC article.
- High hemoglobin fluctuation was a protective factor for cardiovascular-related death in peritoneal dialysis (PD) patients: A retrospective analysis of 232 patients with PD.Liu D, Yang C, Zhou R, Zhao H, Si T, Liu C, Wu Q. Liu D, et al. J Clin Lab Anal. 2022 Jul;36(7):e24548. doi: 10.1002/jcla.24548. Epub 2022 Jun 12. J Clin Lab Anal. 2022. PMID: 35692085 Free PMC article.
- Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study.Xu Y, Evans M, Barany P, James G, Sjölander A, Carrero JJ. Xu Y, et al. Clin Kidney J. 2021 Feb 5;14(7):1780-1788. doi: 10.1093/ckj/sfaa213. eCollection 2021 Jul. Clin Kidney J. 2021. PMID: 34221385 Free PMC article.
- Research Support, Non-U.S. Gov't
- Adult
- Aged
- Anemia / blood*
- Anemia / mortality*
- Bayes Theorem
- Female
- Hemoglobins / metabolism*
- Humans
- Kidney Failure, Chronic / blood*
- Kidney Failure, Chronic / mortality*
- Kidney Failure, Chronic / therapy
- Male
- Middle Aged
- Multivariate Analysis
- Poisson Distribution
- Proportional Hazards Models
- Renal Dialysis
- Retrospective Studies
- Risk Factors
- Hemoglobins
- Full Text Sources
- Other Literature Sources
- Medical
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2390986/bin/cjn0010824560003.jpg)
Source: PubMed